Edwards Lifesciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	49,592	49,471	43,663	46,246	46,128	80,883
Market Cap Growth	19.52%	13.30%	-5.58%	0.25%	-42.97%	42.25%
Enterprise Value	46,596	46,323	39,982	45,142	45,077	79,772
Last Close Price	83.40	85.25	74.03	76.25	74.61	129.55
PE Ratio	46.08	46.08	10.46	32.98	30.31	53.81
Forward PE	28.20	30.93	31.19	28.41	30.35	52.98
PS Ratio	8.20	8.15	8.03	9.23	10.33	15.46
PB Ratio	4.75	4.85	4.34	6.88	7.94	13.86
P/TBV Ratio	6.81	6.77	6.20	9.06	10.59	18.62
P/FCF Ratio	-	-	150.61	71.94	47.38	57.51
P/OCF Ratio	-	-	80.51	51.63	37.87	46.70
PEG Ratio	2.18	3.24	3.69	2.77	2.95	3.38
EV/Sales Ratio	7.68	7.63	7.35	9.01	10.10	15.25
EV/EBITDA Ratio	26.06	25.91	24.44	27.66	26.81	46.34
EV/EBIT Ratio	28.48	28.31	27.00	30.35	29.24	50.28
EV/FCF Ratio	-	-	137.92	70.23	46.30	56.73
Debt / Equity Ratio	0.07	0.07	0.07	0.10	0.12	0.12
Debt / EBITDA Ratio	0.39	0.39	0.42	0.41	0.40	0.39
Debt / FCF Ratio	-	-	2.42	1.07	0.71	0.49
Net Debt / Equity Ratio	-0.31	-0.31	-0.33	-0.14	-0.09	-0.13
Net Debt / EBITDA Ratio	-1.76	-1.76	-2.01	-0.58	-0.31	-0.45
Net Debt / FCF Ratio	-	-	-11.32	-1.47	-0.54	-0.55
Asset Turnover	-	-	0.49	0.57	0.53	0.67
Inventory Turnover	-	-	1.12	1.10	0.90	1.63
Quick Ratio	-	-	3.13	2.06	1.87	2.07
Current Ratio	-	-	4.18	3.38	3.03	3.08
Return on Equity (ROE)	10.42%	10.42%	16.64%	19.48%	22.74%	28.88%
Return on Assets (ROA)	-	-	8.26%	10.53%	11.47%	12.60%
Return on Invested Capital (ROIC)	19.22%	19.60%	21.26%	23.92%	25.98%	31.39%
Return on Capital Employed (ROCE)	-	-	12.80%	18.20%	21.20%	21.20%
Earnings Yield	2.16%	2.17%	9.56%	3.03%	3.30%	1.86%
FCF Yield	-	-	0.66%	1.39%	2.11%	1.74%
Buyback Yield / Dilution	2.25%	2.25%	1.66%	2.37%	1.11%	0.11%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q